Holen Sie sich die Stockscreener-App
9.43
1.87%
-0.18
Schlusskurs vom Vortag:
$9.61
Offen:
$9.33
24-Stunden-Volumen:
1.82M
Relative Volume:
0.50
Marktkapitalisierung:
$672.91M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-192.96M
KGV:
-2.8576
EPS:
-3.3
Netto-Cashflow:
$-167.04M
1W Leistung:
+1.95%
1M Leistung:
+150.80%
6M Leistung:
+516.34%
1J Leistung:
+445.09%
1-Tages-Spanne:
$8.90
$9.595
1-Wochen-Bereich:
$8.90
$10.02
52-Wochen-Spanne:
$0.783
$10.02
Ventyx Biosciences Inc Stock (VTYX) Company Profile
Firmenname
Ventyx Biosciences Inc
Sektor
Branche
Telefon
(760) 407-6511
Adresse
12790 EL CAMINO REAL, SUITE 200, SAN DIEGO
Vergleichen Sie VTYX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VTYX
Ventyx Biosciences Inc
|
9.43 | 685.76M | 0 | -192.96M | -167.04M | -3.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ventyx Biosciences Inc Stock (VTYX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-05 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2024-03-12 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-03-12 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-11-07 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-11-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-07 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2023-11-07 | Herabstufung | Stifel | Buy → Hold |
| 2023-11-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-06-14 | Fortgesetzt | Credit Suisse | Outperform |
| 2023-03-21 | Eingeleitet | Wells Fargo | Overweight |
| 2022-12-19 | Eingeleitet | Goldman | Buy |
| 2022-11-17 | Eingeleitet | Morgan Stanley | Overweight |
| 2022-09-07 | Eingeleitet | Stifel | Buy |
| 2022-09-01 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-05-09 | Eingeleitet | Credit Suisse | Outperform |
| 2022-03-31 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-02-01 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-15 | Eingeleitet | Jefferies | Buy |
| 2021-11-15 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Ventyx Biosciences Inc Aktie (VTYX) Neueste Nachrichten
Will Ventyx Biosciences Inc. stock see insider buyingTrade Exit Summary & Weekly High Potential Stock Alerts - newser.com
Does Ventyx Biosciences Inc. stock trade at a discount to peersMarket Volume Report & Weekly High Return Forecasts - newser.com
Is Ventyx Biosciences Inc. stock attractive for growth ETFsJuly 2025 Trade Ideas & Daily Stock Momentum Reports - newser.com
How Ventyx Biosciences Inc. stock reacts to bond yieldsJuly 2025 Analyst Calls & Verified Momentum Stock Ideas - newser.com
Market reaction to Ventyx Biosciences Inc.’s recent newsGold Moves & Safe Capital Investment Plans - newser.com
Can Ventyx Biosciences Inc. stock double in next 5 years2025 Support & Resistance & Long-Term Growth Stock Strategies - newser.com
Is Ventyx Biosciences Inc. still worth holding after the dipStop Loss & Weekly High Potential Stock Alerts - newser.com
Will Ventyx Biosciences Inc. stock recover faster than peersEarnings Growth Report & Pattern Based Trade Signal System - newser.com
How Ventyx Biosciences Inc. stock performs during Fed tightening cycles2025 Pullback Review & AI Driven Stock Reports - newser.com
Ventyx Biosciences at Jefferies Conference: Strategic Focus on NLRP3 Inhibitors - Investing.com Canada
What high frequency data says about Ventyx Biosciences Inc.Quarterly Investment Review & Real-Time Buy Zone Alerts - newser.com
Why Ventyx Biosciences Inc. is moving todayJuly 2025 Rallies & Target Return Focused Stock Picks - newser.com
VTYX Stock Skyrockets 156% in a Month: Here's What You Need to Know - sharewise.com
Does Ventyx Biosciences Inc. fit your quant trading model2025 Risk Factors & Real-Time Stock Entry Alerts - newser.com
Will Ventyx Biosciences Inc. stock split again soon2025 Key Lessons & Breakout Confirmation Alerts - newser.com
Ventyx Biosciences (VTYX) Price Target Increased by 12.94% to 13.99 - Nasdaq
Ventyx Biosciences to Participate in the Jefferies Global Healthcare Conference in London - The Manila Times
Ventyx Biosciences (Nasdaq: VTYX) schedules Jefferies London fireside chat on Nov. 19 - Stock Titan
Can a trend reversal in Ventyx Biosciences Inc. lead to recoveryMarket Sentiment Review & Weekly High Return Stock Forecasts - newser.com
Published on: 2025-11-16 02:18:59 - newser.com
Is Ventyx Biosciences Inc. stock supported by innovation pipelineShare Buyback & Free Daily Entry Point Trade Alerts - newser.com
Published on: 2025-11-15 13:37:53 - newser.com
Finanzdaten der Ventyx Biosciences Inc-Aktie (VTYX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
1.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):